Form 4: UniFirst Director Joseph Nowicki Receives Equity Grant
Insider Equity Grant
UniFirst Corporation Director Joseph M. Nowicki was granted 575 shares of common stock and 987 stock appreciation rights as part of his fiscal 2026 annual compensation.
Summary
- Joseph M. Nowicki, a Director of UniFirst Corp (UNF), acquired 575 shares of common stock.
- The common stock was awarded under the UniFirst Corporation 2023 Stock Option and Incentive Plan at a price of $0.
- Following this transaction, Mr. Nowicki beneficially owns 2,213 shares of common stock.
- Mr. Nowicki also acquired 987 Stock Appreciation Rights (SARs) with an exercise price of $174.2.
- These SARs are exercisable in full on the grant date of December 16, 2025, and expire on December 16, 2033, or earlier under certain conditions.
- Both the common stock award and the SARs represent annual grants for fiscal year 2026.
Sentiment
Score: 6
Explanation: The filing reports a routine equity grant to a director, which is a neutral to slightly positive event as it aligns director interests with shareholders. It does not contain any unexpected financial news or strategic shifts.
Positives
- Director Joseph M. Nowicki received an equity grant, aligning his interests with shareholders.
- The grant includes both common stock and Stock Appreciation Rights, providing a balanced incentive structure.
Future Outlook
The filing indicates these are annual grants for fiscal year 2026, suggesting a continuation of the company's equity compensation strategy for its directors. The SARs have an expiration date extending to 2033, aligning long-term incentives.
Industry Context
Equity grants to directors and executives are a standard practice across industries, particularly in publicly traded companies, to align management and board interests with those of shareholders. The use of both common stock and Stock Appreciation Rights is a common approach to provide both direct ownership and performance-based incentives.
Comparison to Industry Standards
- The practice of granting equity (common stock and SARs) to directors is standard for public companies, comparable to compensation structures at peers like Cintas Corporation (CTAS) or Aramark (ARMK) in the uniform and facility services industry, which also utilize equity-based incentives to attract and retain talent and align interests.
- The specific number of shares and SARs granted would typically be benchmarked against similar roles at companies of comparable size and industry, though this filing does not provide such comparative data.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy Adherence | The grants are made under the UniFirst Corporation 2023 Stock Option and Incentive Plan, indicating adherence to an established corporate governance framework for executive and director compensation. | 12/16/2025 | Reinforces existing compensation governance structure; no changes to bylaws or policies reported. |
Related Party Transactions
- This filing details a related party transaction, specifically an equity grant from UniFirst Corporation to Joseph M. Nowicki, a director of the company.
Stakeholder Impact
- Shareholders: The grant aligns the director's interests with shareholders, potentially encouraging long-term value creation. It represents a minor dilution of existing shares, typical for routine grants.
- Employees: No direct impact on general employees is indicated.
- Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated.
Key Dates
| Date | Description |
|---|---|
| 12/16/2025 | Date of earliest transaction for common stock and stock appreciation rights acquisition. |
| 12/16/2025 | Grant date for stock appreciation rights, exercisable in full. |
| 12/16/2033 | Expiration date for stock appreciation rights. |
| 12/18/2025 | Signature date of the reporting person's attorney-in-fact. |
Recommendation
holdThis Form 4 filing details a routine annual equity grant to a director, which is a standard compensation practice and does not provide new information that would significantly alter the investment thesis for UniFirst Corporation. While it aligns director interests with shareholders, it's not a catalyst for a 'buy' or 'sell' recommendation. Investors should continue to hold based on broader company fundamentals and market conditions.
Keywords
UniFirst Corporation, UNF, Joseph M. Nowicki, Form 4, SEC Filing, Insider Transaction, Equity Grant, Common Stock, Stock Appreciation Rights, SARs, Director Compensation, Executive Compensation, Stock Option Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.